DrugPatentWatch Database Preview
Dr Reddys Labs Inc Company Profile
What is the competitive landscape for DR REDDYS LABS INC, and when can generic versions of DR REDDYS LABS INC drugs launch?
DR REDDYS LABS INC has forty approved drugs.
There are five US patents protecting DR REDDYS LABS INC drugs. There are two tentative approvals on DR REDDYS LABS INC drugs.
Summary for Dr Reddys Labs Inc
| US Patents: | 5 |
| Tradenames: | 33 |
| Ingredients: | 25 |
| NDAs: | 40 |
Drugs and US Patents for Dr Reddys Labs Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dr Reddys Labs Inc | ZOLPIDEM TARTRATE | zolpidem tartrate | TABLET;SUBLINGUAL | 204503-002 | Nov 18, 2016 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Dr Reddys Labs Inc | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET;ORAL | 077787-002 | Aug 23, 2006 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Dr Reddys Labs Inc | TIZANIDINE HYDROCHLORIDE | tizanidine hydrochloride | TABLET;ORAL | 076286-001 | Jul 3, 2002 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Dr Reddys Labs Inc | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET;ORAL | 077787-001 | Aug 23, 2006 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Dr Reddys Labs Inc | ZIPRASIDONE HYDROCHLORIDE | ziprasidone hydrochloride | CAPSULE;ORAL | 077565-002 | Mar 2, 2012 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Paragraph IV (Patent) Challenges for DR REDDYS LABS INC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Extended-release Tablets | 1000 mg/62.5 mg | ➤ Subscribe | 2009-01-21 |
Non-Orange Book US Patents for Dr Reddys Labs Inc
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 6,294,199 | Method of treating a bacterial infection comprising administering amoxycillin | ➤ Sign Up |
| 6,660,299 | Modified release pharmaceutical formulation comprising amoxycillin | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Dr Reddys Labs Inc Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Sweden | 0001330 | ➤ Sign Up |
| Japan | 2002541187 | ➤ Sign Up |
| Poland | 339591 | ➤ Sign Up |
| Japan | 2002541186 | ➤ Sign Up |
| Canada | 2366304 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Dr Reddys Labs Inc Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2014026,C1506211 | Lithuania | ➤ Sign Up | PRODUCT NAME: DAPAGLIFLOZINUM + METFORMINUM; REGISTRATION NO/DATE: EU/1/13/900 20140116 |
| C/GB11/013 | United Kingdom | ➤ Sign Up | PRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE; REGISTERED: UK PL 17901/0263-0001 20101105 |
| 0443983/03 | Switzerland | ➤ Sign Up | PRODUCT NAME: VALSARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE; REGISTRATION NUMBER/DATE: SWISSMEDIC 59407 16.09.2009 |
| 2014000070 | Germany | ➤ Sign Up | PRODUCT NAME: KOMBINATION VON DAPAGLIFLOZIN ODER EINEM PHARMAZEUTISCH VERTRAEGLICHEN SALZ DAVON, UND METFORMIN ODER EINEM PHARMAZEUTISCH VERTRAEGLICHEN SALZ DAVON, GESCHUETZT DURCH DAS GRUNDPATENT EP 1 506 211; REGISTRATION NO/DATE: EU/1/13/900 20140116 |
| 90013-0 | Sweden | ➤ Sign Up | PRODUCT NAME: SAXAGLIPTIN/METFORMIN; REG. NO/DATE: EU/1/11/731/001 20111124 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.
